認知症に適した運動と福祉プログラムである"Dementia Actif"の評価:混合方法の研究
1School of Medical and Health Sciences, Bangor University, Bangor, UK.
Lancet (London, England)
|November 24, 2023
まとめ
デメンシア・アクティヴ
科学分野:
- ゲロントロジー
- 公衆衛生
- 社会 介護
背景:
- Dementia Actifは,認知症 (PLWD) 患者とその介護者向けに,グループでの運動やクラブを提供しています.
- このプログラムは,運動,ボッチア,ガーデニング,オンライン活動を通じて生活の質を向上させることを目的としています.
- この研究では,イギリス北ウェールズ州のDementia Actifプログラムが評価されています.
研究 の 目的:
- "Dementia Actif"の有効性を評価する
- 認知症患者とその介護者に対する プログラムの影響を評価する
- 認知症のケアにおけるコミュニティベースの介入の利点を特定する.
主な方法:
- 迅速な文献レビュー (2012年−2022年) を含め,複合的なアプローチが用いられました.
- 32人の専門家のインタビューとフォーカスグループが行われました.
- 12人のPLWDとその介護者との活動に関する研究者による観察とインタビューも行われました.
主要な成果:
- 文献のレビューでは 認知症のケアにおける 社会的相互作用と福祉の測定に関する 限られた世界的な証拠が見つかりました
- 評価は,PLWDと介護者のためのアクティブ/ウェルビーイングモデルのポジティブなインパクトを示しました.
- 予防的なコミュニティのリソースは,無給の介護者を支援し,急性治療の必要性を軽減しました.
結論:
- 低コストの社会活動により 認知症患者とその介護者の 福祉が向上します
- デメンシア・アクティヴのアプローチは 個人を力づけることで 複雑なニーズに対応できます
- 発見は,小さなサンプルに基づいて,より広範な適用の可能性を示唆しています.
関連する概念動画
Dementia
117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
117
Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196
Alzheimer's Disease: Overview
496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Cognitive Development During Adulthood
120
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
120
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278


